129 related articles for article (PubMed ID: 20008092)
1. Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Tanaka T; Hagihara K; Shima Y; Narazaki M; Ogata A; Kawase I; Kishimoto T
Rheumatology (Oxford); 2010 Apr; 49(4):824-6. PubMed ID: 20008092
[No Abstract] [Full Text] [Related]
2. Steroid-resistant remitting seronegative symmetrical synovitis with pitting oedema associated with gout treated with etanercept.
Mehta P; Chong S; Carulli MT; Haskard DO
Rheumatology (Oxford); 2014 Oct; 53(10):1908-10. PubMed ID: 24907150
[No Abstract] [Full Text] [Related]
3. Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
Tanaka T; Kuwahara Y; Shima Y; Hirano T; Kawai M; Ogawa M; Arimitsu J; Hagihara K; Narazaki M; Ogata A; Kawase I; Kishimoto T
Arthritis Rheum; 2009 Dec; 61(12):1762-4. PubMed ID: 19950316
[No Abstract] [Full Text] [Related]
4. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) associated with psoriatic arthritis.
Kardes S; Karagulle M; Erdogan N
Scand J Rheumatol; 2015; 44(4):339-40. PubMed ID: 25958968
[No Abstract] [Full Text] [Related]
5. [Remittent seronegative symmetrical synovitis with pitting edema].
Lilleby V; Gran JT
Tidsskr Nor Laegeforen; 1997 Feb; 117(4):517-8. PubMed ID: 9148450
[TBL] [Abstract][Full Text] [Related]
6. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) of hands and feet in an 83-year-old man.
Nygaard U; Vestergaard C; Koppelhus U
Acta Derm Venereol; 2013 Jul; 93(4):491-2. PubMed ID: 23306831
[No Abstract] [Full Text] [Related]
7. Remitting Seronegative Symmetrical Synovitis with Pitting Oedema (RS3PE) Syndrome in a Chronic Kidney Disease Patient Undzergoing Haemodialysis.
Shindo M; Ishii H; Kitano T; Miyazawa H; Ito K; Ueda Y; Hirai K; Kaku Y; Hoshino T; Mori H; Ookawara S; Morishita Y
Nephrology (Carlton); 2016 Dec; 21(12):1073. PubMed ID: 27870229
[No Abstract] [Full Text] [Related]
8. [RS3PE Syndrome: Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A presentation of 3 cases].
Fernández Silva MJ; Vilariño Méndez CR
Semergen; 2012 Oct; 38(7):472-5. PubMed ID: 23021583
[TBL] [Abstract][Full Text] [Related]
9. Remitting seronegative symmetrical synovitis with pitting edema.
Cho E; Kim MH
Arch Dermatol; 2012 Oct; 148(10):1217-8. PubMed ID: 23069977
[No Abstract] [Full Text] [Related]
10. Synovitis with pitting edema as the presenting manifestation of systemic lupus erythematosus.
Hegazi MO; Saleh F; Al Rashidi A; Yaktien MM
Lupus; 2014 Sep; 23(10):1069-72. PubMed ID: 24786784
[TBL] [Abstract][Full Text] [Related]
11. Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.
Filetti M; Anselmi E; Macrini S; Rizzo F; Iacono D; Giusti R; Marchetti P
Semin Arthritis Rheum; 2018 Oct; 48(2):e17-e20. PubMed ID: 29402438
[No Abstract] [Full Text] [Related]
12. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.
Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T
Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169
[No Abstract] [Full Text] [Related]
13. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome) showing dermatomyositis-like eruption.
Takeda K; Fujita J; Fujii T; Tanabe H; Mochizuki T; Yanagihara M
J Dermatol; 2010 Jan; 37(1):102-6. PubMed ID: 20175831
[TBL] [Abstract][Full Text] [Related]
14. [Case of remitting seronegative symmetrical synovitis with pitting edema complicated with Sjogren syndrome].
Tanaka N; Nakano T; Isshiki K; Nagato Y; Tsujie M; Nakayama Y; Kakihara M; Yamada Y; Kamata T; Abe H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1248-50. PubMed ID: 9379104
[No Abstract] [Full Text] [Related]
15. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
Hung SC; Kung YY; Lin HY
J Formos Med Assoc; 1999 Jul; 98(7):516-8. PubMed ID: 10463003
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease.
Gergis U; Arnason J; Yantiss R; Shore T; Wissa U; Feldman E; Woodworth T
J Clin Oncol; 2010 Oct; 28(30):e602-4. PubMed ID: 20713858
[No Abstract] [Full Text] [Related]
17. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
Nishimoto N; Nakahara H; Yoshio-Hoshino N; Mima T
Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and pre-existing diabetes mellitus.
Horai Y; Shimizu T; Okada A; Tokumitsu J; Ikeoka T; Kuriya G; Iwanaga N; Izumi Y; Origuchi T; Kawakami A
Mod Rheumatol; 2022 Jul; 32(4):830-833. PubMed ID: 34908128
[No Abstract] [Full Text] [Related]
19. The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
Shima Y; Kuwahara Y; Murota H; Kitaba S; Kawai M; Hirano T; Arimitsu J; Narazaki M; Hagihara K; Ogata A; Katayama I; Kawase I; Kishimoto T; Tanaka T
Rheumatology (Oxford); 2010 Dec; 49(12):2408-12. PubMed ID: 20819796
[TBL] [Abstract][Full Text] [Related]
20. Interlukin-6 receptor inhibitor tocilizumab: a new treatment option in rheumatoid arthritis?
Johnson J; Wang MY
Neurosurgery; 2008 Aug; 63(2):N8. PubMed ID: 18797345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
